Image Source: Zacks Investment Research In Diagnostics, on a global scale, Abbott has been gaining a prominent position in point-of-care testing, with a portfolio focused on four key areas such as ...

Abbott reported $9.34 billion in diagnostics revenues in 2024, down 7 percent on a reported basis from $9.99 billion in 2023 and down 4 percent on an organic basis. Excluding COVID-19 testing-related ...

Abbott's Diagnostics arm is expected to have been driven by the widespread adoption of its top-tier systems and high testing ...